Q3-FY26 · BL Mittal
We have not delayed a single day payment to any pharmaceutical companies. Our track record is absolutely 100% tight. We have not had any dispute of any single paisa with any pharmaceutical company.
Sastasundarventures · tone and specificity signals across the available quarters.
Language signals
We have not delayed a single day payment to any pharmaceutical companies. Our track record is absolutely 100% tight. We have not had any dispute of any single paisa with any pharmaceutical company.
The company like retailer shaki we have not spent a single penny of acquiring any rights. Whatever money we are spending in building our technology and building our brand, that is paying off to us and will continue to pay in future.
This is a business where only 83 crore rupees we have invested in building the entire IP business including retailer shaki and sastasundar. You can compare any other digital company in India which can demonstrate this kind of capital efficiency and working capital efficiency. I will be happy to learn.